Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 2 2Phase EARLY_PHASE1 1

Status

Completed 8Recruiting 7Unknown 4Not yet recruiting 2Active not recruiting 2Terminated 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 7Observational 3

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 1

Conditions

Breast Neoplasms 1324Neoplasms 982Carcinoma, Non-Small-Cell Lung 860Prostatic Neoplasms 724Colorectal Neoplasms 666Lung Neoplasms 551Leukemia, Myeloid, Acute 475Neoplasm Metastasis 434Pancreatic Neoplasms 419Carcinoma, Hepatocellular 407Multiple Myeloma 396Ovarian Neoplasms 392Stomach Neoplasms 379Recurrence 364Squamous Cell Carcinoma of Head and Neck 325Melanoma 294Brain Neoplasms 287Uterine Cervical Neoplasms 283Triple Negative Breast Neoplasms 271Glioblastoma 264Head and Neck Neoplasms 263Precursor Cell Lymphoblastic Leukemia-Lymphoma 254Endometrial Neoplasms 234Lymphoma 228Rectal Neoplasms 222Esophageal Neoplasms 222Sarcoma 213Carcinoma, Renal Cell 203Colonic Neoplasms 194Lymphoma, Non-Hodgkin 191

Interventions

Mitomycin 2tislelizumab 1molgramostim 1cryoprecipitate coagulum 1Standard of Care 1Hyperthermic Intraperitoneal Chemotherapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Recruiting × Interventional × Pseudomyxoma Peritonei × Clear all
NCT04779554 2026-04-01

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

University of Kentucky

Phase 2 Recruiting
100 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT06617897 2026-03-11

Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery

CSL Behring

Phase 3 Recruiting
90 enrolled

Afibrinogenemia, Blood Coagulation Disorders, Pseudomyxoma Peritonei

NCT06513065 2026-02-19

HIPEC-PMP

University of Southampton

Phase 3 Recruiting
176 enrolled

Pseudomyxoma Peritonei

NCT04024917 2026-01-16

COCOON

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting
60 enrolled
Gynecologic

Peritoneal Neoplasms, Pseudomyxoma Peritonei

NCT07341360 2026-01-14

Pseudovax

Oslo University Hospital

Phase EARLY_PHASE1 Recruiting
10 enrolled

Pseudomyxoma Peritonei

NCT07328737 2026-01-09

One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei

Beijing Tsinghua Chang Gung Hospital

Phase NA Recruiting
132 enrolled

Pseudomyxoma Peritonei

NCT06800391 2025-01-30

REVERSE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Recruiting
31 enrolled

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon âš¡